Coverage policy updates

Policy changes Backwork has recorded, newest first. The most recent change on record is from October 24, 2026. Changes appear here after Backwork reviews and applies a refresh, so this page can trail the payers’ own sites.

Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.

Recorded changes

86,510 on record

Recorded policy changes, newest first
Recorded	Payer	Policy	Change
Aug 2, 2026	Blue Cross Blue Shield of Michigan and Blue Care Network	INTENSITY MODULATED RADIATION THERAPY (IMRT) AND IMAGE GUIDED RADIATION THERAPY (IGRT): CENTRAL NERVOUS SYSTEM TUMORSPayerPolicy · BCBSM-2047282	New policy
Aug 2, 2026	Blue Cross Blue Shield of Michigan and Blue Care Network	MULTIMARKER SERUM TESTING RELATED TO OVARIAN CANCER (E.G., OVA1, OVERA, OVAWATCH AND ROMA TESTING) - MEDICARE ADVANTAGEPayerPolicy · BCBSM-2193630	New policy
Aug 2, 2026	Blue Cross Blue Shield of Michigan and Blue Care Network	CONTRAST-ENHANCED COMPUTED TOMOGRAPHY ANGIOGRAPHY (CTA, CCTA, MDCT, MSCT) OF THE HEART AND/OR CORONARY ARTERIES - MEDICARE ADVANTAGEPayerPolicy · BCBSM-2193017	New policy
Aug 2, 2026	Blue Cross Blue Shield of Michigan and Blue Care Network	STEERABLE URETOEROSCOPIC RENAL EVACUATION (SURE PROCEDURE) WITH VACCUUM-ASSISTED STONE REMOVAL SYSTEMS FOR KIDNEY STONE MANAGEMENTPayerPolicy · BCBSM-2203139	New policy
Aug 2, 2026	Blue Cross Blue Shield of Michigan and Blue Care Network	DIGITAL HEALTH TECHNOLOGIES: DIAGNOSTIC APPLICATIONS (BEHAVIORAL HEALTH DISORDERS INCLUDING AUTISM SPECTRUM DISORDER) - MEDICARE ADVANTAGEPayerPolicy · BCBSM-2199977	New policy
Aug 2, 2026	Blue Cross Blue Shield of Michigan and Blue Care Network	GENETIC TESTING FOR MARFAN SYNDROME, EHLERS-DANLOS, THORACIC AORTIC ANEURYSMS AND DISSECTIONS, AND CONNECTIVE TISSUE RELATED DISORDERSPayerPolicy · BCBSM-2005615	New policy
Aug 2, 2026	Blue Cross Blue Shield of Michigan and Blue Care Network	PHRENIC NERVE STIMULATION AND DIAPHRAGM PACING (E.G., MARK IV, NEURX, DPS, AND RA/4) - MEDICARE ADVANTAGEPayerPolicy · BCBSM-2197884	New policy
Aug 2, 2026	Blue Cross Blue Shield of Michigan and Blue Care Network	BCN ONLY: TELEMEDICINE (end date 04/30/2020) see joint policy Doc ID: 2121766PayerPolicy · BCBSM-2089117	New policy
Aug 2, 2026	Blue Cross Blue Shield of Michigan and Blue Care Network	TEMPORARILY IMPLANTED PROSTATIC STENTS FOR BENIGN PROSTATIC HYPERPLASIA (E.G., NITINOL DEVICE [ITIND], SPANNERTM) - MEDICARE ADVANTAGEPayerPolicy · BCBSM-2195915	New policy
Aug 2, 2026	Blue Cross Blue Shield of Michigan and Blue Care Network	INTENSITY MODULATED RADIATION THERAPY (IMRT) AND IMAGE GUIDED RADIATION THERAPY (IGRT): CANCER OF THE HEAD AND NECK OR THYROIDPayerPolicy · BCBSM-2047285	New policy
Aug 2, 2026	Blue Cross Blue Shield of Michigan and Blue Care Network	GT-SOMATIC BIOMARKER TESTING FOR IMMUNE CHECKPOINT INHIBITOR THERAPY (BRAF, MSI/MMR, PD-L1, TMB)PayerPolicy · BCBSM-2183397	New policy
Aug 2, 2026	Blue Cross Blue Shield of Michigan and Blue Care Network	BONE MARROW TRANSPLANT - HEMATOPOIETIC CELL TRANSPLANTATION FOR CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA - AUTOLOGOUS AND ALLOGENEICPayerPolicy · BCBSM-2026685	New policy
Aug 2, 2026	Blue Cross Blue Shield of Michigan and Blue Care Network	CIRCULATING TUMOR DNA AND CIRCULATING TUMOR CELLS FOR SELECTING TARGETED THERAPY FOR ADVANCED SOLID CANCERS (LIQUID BIOPSY)PayerPolicy · BCBSM-2002479	New policy
Aug 2, 2026	Blue Cross Blue Shield of Michigan and Blue Care Network	DRUG COATED BALLOON FOR URETHRAL STRICTURES (I.E., OPTILUME URETHRAL DRUG COATED BALLOON) - MEDICARE ADVANTAGEPayerPolicy · BCBSM-2204978	New policy
Aug 2, 2026	Blue Cross Blue Shield of Michigan and Blue Care Network	GENETIC TESTING - NEXT GENERATION SEQUENCING FOR ASSESSMENT OF MEASURABLE RESIDUAL DISEASE (E.G, CLONOSEQ) IN HEMATOLOGICAL MALIGNANCIESPayerPolicy · BCBSM-2181828	New policy
Aug 2, 2026	Blue Cross Blue Shield of Michigan and Blue Care Network	GENETIC TESTING FOR CARDIAC ION CHANNELOPATHIES (E.G., CONGENITAL LONG QT SYNDROME, BRUGADA SYDROME, ETC.)PayerPolicy · BCBSM-2001707	New policy
Aug 2, 2026	Blue Cross Blue Shield of Michigan and Blue Care Network	GENETIC TESTING FOR LYNCH SYNDROME AND OTHER INHERITED COLON CANCER SYNDROMES (EFFECTIVE 07/01/2026)PayerPolicy · BCBSM-2209374-F4002587D8	New policy
Aug 2, 2026	Blue Cross Blue Shield of Michigan and Blue Care Network	BONE TURNOVER MARKERS FOR DIAGNOSIS AND MANAGEMENT OF OSTEOPOROSIS AND DISEASES ASSOCIATED WITH HIGH BONE TURNOVER - MEDICARE ADVANTAGEPayerPolicy · BCBSM-2192446	New policy
Aug 2, 2026	Blue Cross Blue Shield of Michigan and Blue Care Network	GENETIC TESTING FOR THE DIAGNOSIS AND MANAGEMENT OF PANCREATIC CYSTS, AND SOLID PANCREATICOBILIARY LESIONS (E.G., PATHFINDER TG, PANCRAGEN)PayerPolicy · BCBSM-2002382	New policy
Aug 2, 2026	Blue Cross Blue Shield of Michigan and Blue Care Network	SKIN ADVANCED GLYCATION END PRODUCTS (AGE) MEASUREMENT BY MULTI-WAVELENGTH FLUORESCENT SPECTROSCOPY - MEDICARE ADVANTAGEPayerPolicy · BCBSM-2194713	New policy
Aug 2, 2026	Blue Cross Blue Shield of Michigan and Blue Care Network	CONTINUOUS SUBCUTANEOUS INSULIN INFUSION (CSII) (INSULIN PUMPS) AND TRANSDERMAL INSULIN DELIVERY SYSTEMS - MEDICARE ADVANTAGEPayerPolicy · BCBSM-2197259	New policy
Aug 2, 2026	Blue Cross Blue Shield of Michigan and Blue Care Network	MONOCHROMATIC INFRARED ENERGY (MIRE) DEVICE FOR THE TREATMENT OF CUTANEOUS ULCERS, DIABETIC NEUROPATHY AND MISCELLANEOUS MUSCULOSKELETAL CONDITIONSPayerPolicy · BCBSM-82722	New policy
Aug 2, 2026	Blue Cross Blue Shield of Michigan and Blue Care Network	BONE MARROW TRANSPLANT HEMATOPOIETIC CELL TRANSPLANTATION FOR MYELODYSPLASTIC SYNDROMES AND MYELOPROLIFERATIVE NEOPLASMS, ALLOGENEIC - MEDICARE ADVANTAGEPayerPolicy · BCBSM-2195972	New policy
Aug 2, 2026	Blue Cross Blue Shield of Michigan and Blue Care Network	BMT - HEMATOPOIETIC CELL TRANSPLANTATION FOR ACUTE MYELOID LEUKEMIA AND BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM (BPDCN)PayerPolicy · BCBSM-2027400	New policy
Aug 2, 2026	Blue Cross Blue Shield of Michigan and Blue Care Network	GERMLINE GENETIC TESTING FOR GENE VARIANTS ASSOCIATED WITH BREAST CANCER IN INDIVIDUALS AT HIGH BREAST CANCER RISKPayerPolicy · BCBSM-2185397	New policy
Aug 2, 2026	Blue Cross Blue Shield of Michigan and Blue Care Network	CIRCULATING TUMOR DNA FOR MANAGEMENT OF NON-SMALL-CELL LUNG CANCER (LIQUID BIOPSY) - MEDICARE ADVANTAGEPayerPolicy · BCBSM-2198908	New policy
Aug 2, 2026	Blue Cross Blue Shield of Michigan and Blue Care Network	LABORATORY TESTS POST TRANSPLANT (KIDNEY, HEART, AND LUNG) AND FOR HEART FAILURE (EFFECTIVE 09/01/2026)PayerPolicy · BCBSM-2210516-1AB65D2F68	New policy
Aug 2, 2026	Blue Cross Blue Shield of Michigan and Blue Care Network	IN-OFFICE NEEDLE ARTHROSCOPY (E.G., MI-EYE 2, MI-EYE 3 NEEDLESCOPE WITH CANNULA, AND VISIONSCOPE¿)PayerPolicy · BCBSM-2117564	New policy
Aug 2, 2026	Blue Cross Blue Shield of Michigan and Blue Care Network	GENETIC TESTING-BRAF/NTRK MUTATION IN SELECTING MELANOMA PATIENTS FOR TARGETED THERAPY INCLUDING LIQUID BIOPSYPayerPolicy · BCBSM-2097766	New policy
Aug 2, 2026	Blue Cross Blue Shield of Michigan and Blue Care Network	ORTHOPEDIC APPLICATIONS OF STEM-CELL THERAPY (INCLUDING ALLOGRAFTS AND BONE SUBSTITUTES USED WITH AUTOLOGOUS BONE MARROW)PayerPolicy · BCBSM-2026114	New policy
Aug 2, 2026	Blue Cross Blue Shield of Michigan and Blue Care Network	LIGHT AND LASER THERAPY FOR VITILIGO AND ECZEMA (INCLUDING FRAGILE XE SYNDROME) (EFFECTIVE 09/01/2026)PayerPolicy · BCBSM-2210509-4F57AFA1F1	New policy
Aug 2, 2026	Blue Cross Blue Shield of Michigan and Blue Care Network	INTERFERON LAMBDA 3 (IFNL3) TESTING TO PREDICT RESPONSE TO TREATMENT OF HEPATITIS C VIRUS (HCV) INFECTIONPayerPolicy · BCBSM-2095741	New policy
Aug 2, 2026	Blue Cross Blue Shield of Michigan and Blue Care Network	GROWING RODS FOR SCOLIOSIS (E.G., MAGEC SPINAL BRACING AND DISTRACTION SYSTEM) (EFFECTIVE 07/01/2026)PayerPolicy · BCBSM-2209376-52473931AB	New policy
Aug 2, 2026	Blue Cross Blue Shield of Michigan and Blue Care Network	INTENSITY-MODULATED RADIATION THERAPY (IMRT) AND IMAGE GUIDED RADIATION THERAPY (IGRT): ABDOMEN, PELVIS, AND CHESTPayerPolicy · BCBSM-2047279	New policy
Aug 2, 2026	Blue Cross Blue Shield of Michigan and Blue Care Network	PERCUTANEOUS ELECTRICAL NERVE FIELD STIMULATION (E.G., IB-STIM) FOR FUNCTIONAL GASTROINTESTINAL DISORDERS INCLUDING IBSPayerPolicy · BCBSM-2196616	New policy
Aug 2, 2026	Blue Cross Blue Shield of Michigan and Blue Care Network	ABLATION OF PERIPHERAL NERVES TO TREAT PAIN INCLUDING COOLIEF COOLED RF AND IOVERA° SYSTEM - MEDICARE ADVANTAGEPayerPolicy · BCBSM-2199976	New policy
Aug 2, 2026	Blue Cross Blue Shield of Michigan and Blue Care Network	BONE MARROW TRANSPLANT - HEMATOPOIETIC CELL TRANSPLANT FOR GENETIC DISEASES AND ACQUIRED ANEMIAS, ALLOGENEIC - MEDICARE ADVANTAGEPayerPolicy · BCBSM-2195787	New policy
Aug 2, 2026	Blue Cross Blue Shield of Michigan and Blue Care Network	ACCELERATED BREAST IRRADIATION AND BRACHYTHERAPY BOOST AFTE BREAST-CONSERVING SURGERY FOR EARLY-STAGE BREAST CANCER.PayerPolicy · BCBSM-77496	New policy
Aug 2, 2026	Blue Cross Blue Shield of Michigan and Blue Care Network	BMT- HEMATOPOIETIC CELL TRANSPLANTATION (HCT) FOR CNS TUMORS, EMBRYONAL TUMORS, AND EPENDYMOMA - MEDICARE ADVANTAGEPayerPolicy · BCBSM-2195785	New policy
Aug 2, 2026	Blue Cross Blue Shield of Michigan and Blue Care Network	NONINVASIVE MEASUREMENT OF CENTRAL BLOOD PRESSURE (SPHYGMOCOR SYSTEM, VICORDER, PULSE WAVE VELOCITY, PHYSIOWAVE)PayerPolicy · BCBSM-2069439	New policy
Aug 2, 2026	Blue Cross Blue Shield of Michigan and Blue Care Network	BMT-HCT GENE THERAPIES FOR SICKLE CELL DISEASE (AUTOLOGOUS) (EFFECTIVE 09/01/2026)PayerPolicy · BCBSM-2210518-B6A69F782D	New policy
Aug 2, 2026	Blue Cross Blue Shield of Michigan and Blue Care Network	GENETIC TESTING - MALIGNANT GLIOMAS INCLUDING MGMT PROMOTER METHYLATION (EFFECTIVE 07/01/2026)PayerPolicy · BCBSM-2209375-0A9FD2B928	New policy
Aug 2, 2026	Blue Cross Blue Shield of Michigan and Blue Care Network	GENETIC TESTING (SINGLE NUCLEOTIDE VARIANTS) TO PREDICT RISK OF NONFAMILIAL BREAST CANCER - MEDICARE ADVANTAGEPayerPolicy · BCBSM-2198901	New policy
Aug 2, 2026	Blue Cross Blue Shield of Michigan and Blue Care Network	JYNNEOS (SMALLPOX AND MONKEYPOX, LIVE, NON-REPLICATING VACCINE) policy retired as of 12/3/2020.PayerPolicy · BCBSM-2117667	New policy
Aug 2, 2026	Blue Cross Blue Shield of Michigan and Blue Care Network	TEMPORARILY IMPLANTED PROSTATIC DEVICES FOR BENIGN PROSTATIC HYPERPLASIA (E.G., NITINOL DEVICE [ITIND], SPANNERTM)PayerPolicy · BCBSM-2181057	New policy
Aug 2, 2026	Blue Cross Blue Shield of Michigan and Blue Care Network	EXTRACORPOREAL SHOCK WAVE THERAPY FOR TREATMENT OF PLANTAR FASCIITIS AND OTHER MUSCULOSKELETAL DISORDERS - MEDICARE ADVANTAGEPayerPolicy · BCBSM-2193212	New policy
Aug 2, 2026	Blue Cross Blue Shield of Michigan and Blue Care Network	CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY WITH SELECTIVE NONINVASIVE FRACTIONAL FLOW RESERVE (FFRCT) - MEDICARE ADVANTAGEPayerPolicy · BCBSM-2201629	New policy
Aug 2, 2026	Blue Cross Blue Shield of Michigan and Blue Care Network	GENETIC TESTING - WHOLE EXOME AND WHOLE GENOME SEQUENCING FOR DIAGNOSIS OF GENETIC DISORDERS - MEDICARE ADVANTAGEPayerPolicy · BCBSM-2198600	New policy
Aug 2, 2026	Blue Cross Blue Shield of Michigan and Blue Care Network	GENETIC TESTING - NGS OF MULTIPLE GENES (PANEL) FOR SOLID AND HEMATOLYMPHOID MALIGNANT CONDITIONS - MEDICARE ADVANTAGEPayerPolicy · BCBSM-2198890	New policy
Aug 2, 2026	Blue Cross Blue Shield of Michigan and Blue Care Network	RADIOFREQUENCY ABLATION OF PERIPHERAL NERVES TO TREAT PAIN INCLUDING COOLIEF COOLED RF - MEDICARE ADVANTAGEPayerPolicy · BCBSM-2194668-923B2A3344	New policy